ArticleFrontiers in immunology2024

Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder: a case series report.

Hesham Abboud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.